Accordingly, several reports have shown that BMP-4 is expressed in low-grade gliomas, and that it serves as a favorable prognostic marker in gliomas (Bao et al., 2013; Nayak et al., 2020). The gene discussed is BMP4; the disease is central nervous system cancer.